Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Psyence Biomedical Ltd’s stock clocked out at $2.01, up 18.24% from its previous closing price of $1.70. In other words, the price has increased by $18.24 from its previous closing price. On the day, 0.87 million shares were traded. PBM stock price reached its highest trading level at $2.25 during the session, while it also had its lowest trading level at $1.64.
Ratios:
To gain a deeper understanding of PBM’s stock, we examine its different ratios.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PBM now has a Market Capitalization of 8898531 and an Enterprise Value of 33839432.
Stock Price History:
The Beta on a monthly basis for PBM is -0.42, which has changed by -0.9977311 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, PBM has reached a high of $945.15, while it has fallen to a 52-week low of $1.51. The 50-Day Moving Average of the stock is -37.42%, while the 200-Day Moving Average is calculated to be -93.32%.
Shares Statistics:
It appears that PBM traded 2.43M shares on average per day over the past three months and 253300 shares per day over the past ten days. A total of 0.72M shares are outstanding, with a floating share count of 0.55M. Insiders hold about 23.47% of the company’s shares, while institutions hold 5.49% stake in the company. Shares short for PBM as of 1734048000 were 137684 with a Short Ratio of 0.03, compared to 1731628800 on 10984. Therefore, it implies a Short% of Shares Outstanding of 137684 and a Short% of Float of 17.69.
